BioLineRx Receives Orphan Drug Designation for Novel Stem Cell Mobilization Treatment
BKT-140/BL-8040 previously received Orphan Drug Designation for treatment of Acute Myeloid Leukemia.
BKT-140/BL-8040 is expected to commence Phase 1 trial in stem cell mobilization in Q2 2014, and top-line results are expected in H2 2014.